We are live on ! Find out more
CRB

Chad R. Baker Portfolio holdings

AUM $620M
1-Year Est. Return 42.67%
This Fund
S&P 500
This Quarter Est. Return
+8.97%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.07%
10 Year Est. Return
+563.15%
AUM
$445M
AUM Growth
+$27.4M
Cap. Flow
-$6.37M
Cap. Flow %
-1.43%
Top 10 Hldgs %
42.16%
Holding
54
New
1
Increased
Reduced
5
Closed
3

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$4.71M

Sector Composition

Rank Sector Weight
1 Technology 23.49%
2 Healthcare 21.12%
3 Industrials 16.32%
4 Consumer Discretionary 12.03%
5 Communication Services 11.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SJM icon
51
J.M. Smucker
SJM
$14.1B
$220K 0.05%
1,700
IFF icon
52
International Flavors & Fragrances
IFF
$22.4B
-10,000
Closed -$1.4M
NVS icon
53
Novartis
NVS
$292B
-9,315
Closed -$796K
CDK
54
DELISTED
CDK Global, Inc.
CDK
-10,833
Closed -$586K

Similar funds

Chad R. Baker's Q2 2021 Portfolio in Review

As of Q2 2021, Chad R. Baker held 54 positions worth $445M, up 6.6% from $417M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Chad R. Baker's Q2 2021 filing shows 1 new, 5 reduced and 3 closed positions. Its largest new stake was Medtronic: 37,550 shares worth $4.66M. The largest sale was Fiserv Inc, an estimated $3.38M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

  • Chad R. Baker's largest Q2 2021 buy was Medtronic: 37,550 shares worth $4.66M.
  • Chad R. Baker's biggest Q2 2021 reduction was Fiserv Inc, cutting an estimated $3.38M.
  • Chad R. Baker fully exited International Flavors & Fragrances in Q2 2021, selling an estimated $1.4M.
  • Chad R. Baker's ten largest holdings make up 42% of its $445M portfolio in Q2 2021.
  • Chad R. Baker opened 1 new position and closed 3 in Q2 2021.
  • Chad R. Baker's portfolio value rose 6.6% quarter-over-quarter to $445M.

Based on Chad R. Baker's 13F filing for Q2 2021, filed 4 Aug 2021.